![]() |
市場調査レポート
商品コード
756666
インスリンペンの世界市場:2019年~2023年Global Insulin Pens Market 2019-2023 |
インスリンペンの世界市場:2019年~2023年 |
出版日: 2018年11月12日
発行: TechNavio (Infiniti Research Ltd.)
ページ情報: 英文 107 Pages
納期: 即納可能
![]() |
2型糖尿病向けスマートインシュリンペンの開発に焦点を当てることによって、市場の成長が促進される可能性が高くなっています。企業は、先進技術を製品やサービスに組み込むことで、市場での成長に努めています。 Technavioのアナリストは、世界のインスリンペン市場が2023年までに約9%のCAGRで成長すると予測しています。
当レポートでは、世界のインスリンペン市場について調査分析し、市場規模と成長率、市場動向、市場促進要因・課題、市場機会について検証するほか、主要ベンダーなどについて、体系的な情報を提供しています。
The increasing focus on development of smart insulin pens for type 2 diabetes is likely to drive growth in the market. Companies are striving to grow in the market by incorporating advanced technologies into their products and services. Technavio's analysts have predicted that the insulin pens market will register a CAGR of close to 9% by 2023.
Growing incidence of diabetes have increased the demand for insulin pens in the market.
Product recalls pose as a biggest threat to the market. Regulatory bodies and companies recalling products can impact the sales and a company's brand image.
For the detailed list of factors that will drive and challenge the growth of the insulin pens market during the 2019-2023, view our report.
The market appears to be concentrated and with the presence of few companies including BD and Eli Lilly the competitive environment is quite intense. Factors such as the increasing focus on development of smart insulin pens and the incidences of diabetes, will provide considerable growth opportunities to insulin pens manufactures. BD, Eli Lilly, Sanofi, and Novo Nordisk are some of the major companies covered in this report.
'With the presence of a considerable number of companies, this market appears to be concentrated. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.'